NAN BING signed D2M Biotherapeutics Inc.'s 2023 Form 5500 as plan administrator.
Signer names are public record from the Form 5500 e-signature.
D2M Biotherapeutics Inc.'s EIN is 85-2295555.
Download the official 2023 Form 5500 (PDF) for D2M Biotherapeutics Inc. from the U.S. Department of Labor's EFAST2 system.
Download the official 2023 Form 5500 (PDF)D2M Biotherapeutics Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).